Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

CROs juggle uncertainty, optimism

Tuesday, August 10th, 2010

The latest earnings season for the top publicly traded contract research organizations is over (Parexel released fiscal year 2010 results yesterday), leaving eyes now focused ahead at just what path clinical outsourcing will take the rest of the year and beyond. Many CROs are unsure whether continued market conditions will ...

Emerging markets push has CRO at ready

Wednesday, December 2nd, 2009

A common theme echoed by big pharma these days, particularly during the recent blitz of third-quarter earnings releases, is a renewed focus on emerging markets. (Sanofi-Aventis and GlaxoSmithKline are two notable examples). Of course, the importance of tapping emerging markets – both for drug research and commercial medicines – has ...

   
©2012 UBM Canon